Written and maintained by CASRAI Editorial Board
Last updated
Cardiac risk stratification (or cardiovascular risk stratification) is the quantitative clinical process of estimating a patient’s probability of experiencing a Major Adverse Cardiac Event (MACE)—such as myocardial infarction, unstable angina requiring urgent revascularization, heart failure hospitalization, or cardiovascular death—over a defined time horizon. Because no single calculator applies to every clinical encounter, American Heart Association and American College of Cardiology (AHA/ACC) guidelines divide cardiac risk stratification into three distinct clinical settings: acute coronary syndrome (ACS / NSTEMI) triage, outpatient primary prevention of coronary artery disease (CAD), and preoperative noncardiac surgical clearance.
What Is Cardiac Risk Stratification?
In both clinical cardiology and health services risk stratification, predictive scoring models combine demographic variables, comorbidities, electrocardiogram (ECG) findings, and cardiac biomarkers (such as high-sensitivity cardiac troponin, hs-cTn, and natriuretic peptides) into validated probability tiers. Selecting the correct cardiac risk stratification calculator depends on whether the patient is asymptomatic in an ambulatory clinic, presenting to the emergency department with acute chest pain, or undergoing preoperative evaluation:
| Clinical Scenario | Validated Risk Calculators | Prediction Horizon & Endpoint | Guideline Reference |
|---|---|---|---|
| Acute Chest Pain & Suspected ACS / NSTEMI | HEART Score, TIMI Score, GRACE 2.0 Score, EDACS | 30-day to 6-week MACE (HEART); 14-day mortality/MI/revascularization (TIMI); in-hospital & 6-month mortality (GRACE) | 2021 AHA/ACC Chest Pain Guideline |
| Primary Prevention & Chronic CAD Risk | ASCVD Risk Estimator (Pooled Cohort Equations) & AHA PREVENT Equations | 10-year and 30-year risk of fatal/nonfatal MI, stroke, and heart failure in adults aged 30–79 without known CVD | 2023/2024 AHA PREVENT Scientific Statement |
| Preoperative Noncardiac Surgery | Revised Cardiac Risk Index (RCRI / Lee Index), ACS NSQIP MICA | 30-day perioperative myocardial infarction, pulmonary edema, ventricular fibrillation/cardiac arrest, or complete heart block | 2024 AHA/ACC Perioperative Guideline |
ACS and NSTEMI Risk Stratification: HEART, TIMI, and GRACE Scores
Under the 2021 AHA/ACC Chest Pain Guideline and ACC/AHA Non-ST-Elevation Acute Coronary Syndromes (NSTE-ACS) guidelines, patients presenting with acute chest pain after ST-elevation myocardial infarction (STEMI) is excluded by a 10-minute 12-lead ECG undergo structured risk stratification using hs-cTn accelerated diagnostic protocols (0/1-hour or 0/2-hour delta algorithms) paired with clinical scores:
- HEART Score (0–10 Points): Evaluates History, ECG, Age, Risk factors, and Troponin (0, 1, or 2 points each) for undifferentiated emergency department chest pain. Scores of 0–3 (Low Risk, <2% MACE) support safe early ED discharge; 4–6 (Moderate Risk) warrant observation and serial troponin/noninvasive testing; 7–10 (High Risk) warrant early invasive cardiology consultation.
- TIMI Risk Score for UA/NSTEMI (0–7 Points): Assigns 1 point each for Age ≥ 65, ≥ 3 CAD risk factors, known CAD (stenosis ≥ 50%), aspirin use in the past 7 days, ≥ 2 anginal events in 24 hours, ST-segment deviation ≥ 0.5 mm, and elevated cardiac biomarkers. Scores of 0–2 indicate low risk, 3–4 intermediate risk, and 5–7 high risk.
- GRACE 2.0 Score & Invasive Timing in NSTEMI: Integrates age, heart rate, systolic blood pressure, serum creatinine, Killip class, cardiac arrest at admission, ST-segment deviation, and elevated cardiac enzymes. In confirmed NSTEMI, AHA/ACC guidelines stratify invasive coronary angiography timing into Immediate Invasive (< 2 hours) for refractory angina, hemodynamic instability, or electrical instability; Early Invasive (< 24 hours) for high-risk patients with a GRACE score > 140; and Delayed/Selective Invasive (25–72 hours) for lower-risk presentations.
Primary Prevention & Preoperative RCRI Guidelines
Outside the acute emergency setting, cardiovascular risk stratification guides lipid-lowering therapy, noninvasive coronary anatomical/functional imaging, and surgical clearance:
- Outpatient Primary Prevention (PCE vs. AHA PREVENT): The 2013 ACC/AHA Pooled Cohort Equations categorize 10-year ASCVD risk into Low (<5%), Borderline (5%–7.4%), Intermediate (7.5%–19.9%, where a Coronary Artery Calcium [CAC] score ≥ 100 Agatston units or ≥ 75th percentile reclassifies patients upward), and High (≥20%). The newer AHA PREVENT equations remove race from risk modeling, expand the age range to 30–79 years, add estimated glomerular filtration rate (eGFR) and optional HbA1c/UACR, and estimate both 10-year and 30-year ASCVD and heart failure risk.
- Preoperative Noncardiac Surgery (Revised Cardiac Risk Index — RCRI): The 2024 AHA/ACC Perioperative Guideline uses the 6-point Lee RCRI calculator (1 point each for high-risk suprainguinal vascular/intraperitoneal/intrathoracic surgery, history of ischemic heart disease, history of congestive heart failure, history of cerebrovascular disease, preoperative insulin treatment, and preoperative creatinine > 2.0 mg/dL). Patients with RCRI 0–1 have low risk (<1% MACE) and proceed to surgery without further cardiac testing; patients with Elevated Risk (RCRI ≥ 2 or ≥ 1% predicted MACE) undergo functional capacity assessment (≥ 4 METs or Duke Activity Status Index [DASI] > 34 vs. poor/unknown capacity).
Cardiac Risk Stratification ICD-10-CM Coding Reference
In EHR clinical documentation and claims workflows, ICD-10-CM does not assign a standalone diagnosis code for the act of running a risk score; instead, clinicians code the underlying clinical syndrome, preoperative examination, or cardiovascular risk factors:
- Preoperative Cardiovascular Examination:
Z01.810(Encounter for preprocedural cardiovascular examination). - Acute Coronary Syndrome & Chest Pain Presentations:
I21.4(Non-ST elevation [NSTEMI] myocardial infarction),I20.0(Unstable angina),R07.9(Chest pain, unspecified),R07.89(Other chest pain). - Chronic Coronary Artery Disease & Risk Factors:
I25.10(Atherosclerotic heart disease of native coronary artery without angina pectoris),Z82.49(Family history of ischemic heart disease and other diseases of the circulatory system),Z79.899(Other long term current drug therapy).
Frequently Asked Questions
What is cardiac risk stratification?
Cardiac risk stratification is the structured clinical evaluation of a patient’s short-term or long-term probability of suffering a major adverse cardiac event (such as myocardial infarction, cardiac arrest, or cardiovascular death) using validated scoring systems like the HEART, TIMI, GRACE, AHA PREVENT, or RCRI calculators.
How is cardiac risk stratification used in clinical research and healthcare?
In clinical care, cardiac risk stratification determines whether an emergency department chest pain patient can be safely discharged (HEART ≤ 3), when an NSTEMI patient requires invasive angiography (GRACE > 140 within 24 hours), whether an outpatient warrants statin therapy (ASCVD/PREVENT), and whether a surgical patient needs preoperative stress testing (RCRI). In clinical trials, risk scores standardize baseline cohort enrichment and endpoint adjudication.
